首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
医药化合物
摘要
本发明提供4–(2,6–二氯–苯甲醯胺基)–1H–唑–3–羧酸啶–4–基醯胺之酸加成盐和其结晶,该盐系与选自甲烷磺酸和乙酸及其混合物之酸形成。也提供4–(2,6–二氯–苯甲醯胺基)–1H–唑–3–羧酸啶–4–基醯胺之盐的新颖用途、制备4–(2,6–二氯–苯甲醯胺基)–1H–唑–3–羧酸啶–4–基醯胺和其盐之方法及新颖化学中间物。095101703-p01.bmp
申请公布号
TW200639167
申请公布日期
2006.11.16
申请号
TW095101703
申请日期
2006.01.17
申请人
额斯泰克斯医疗公司
发明人
大卫 查理斯 利斯;盖理 特瑞华沙;拉登 温寇维克;保罗 格雷恩 怀尔特
分类号
C07D401/12(2006.01);A61K31/4155(2006.01);A61K31/454(2006.01);A61P35/00(2006.01);A61P35/02(2006.01)
主分类号
C07D401/12(2006.01)
代理机构
代理人
桂齐恒
主权项
地址
英国
您可能感兴趣的专利
Methods for regulating cancer
Priming vaccine comprising a polynucleotide encoding at least one first malarial antigen and a boosting vaccine comprising at least one polypeptide comprising at least one second malarial antigen having at least one epitope in common with the first malarial antigen of the priming vaccine
METHOD AND APPARATUS FOR PROVIDING FEEDBACK CORRESPONDING TO MOVEMENT OF A CONTROLLED OBJECT
GENES DIFFERENTIALLY EXPRESSED DURING EARLY EMBRYONIC DEVELOPMENT IN AVIANS
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
Computer-implemented method of selecting a profiled element for a load-bearing structure
Improved resistored anode construction
Method and apparatus for conducting electronic retail financial transactions
Advertising display panel with diffusion of scents
Teat cup assembly
Pallet gripper with tines having actuators to internally grip pallet bearers
Lever operated throttle control device with safety stop to hold throttle in idle position against releasable bias
POTENCIADORES DEL RECEPTOR AMPA
PREPARACIÓN Y USO DE DERIVADOS DE TETRAHIDROPIRROLO[3,2-C]PIRIDIN-4-ONA PARA EL TRATAMIENTO DE LA OBESIDAD, TRASTORNOS PSIQUIÁTRICOS Y NEUROLÓGICOS
ALQUIL SULFÓXIDO QUINOLINAS COMO LIGANDOS DEL RECEPTOR NK-3
NUEVOS DERIVADOS IMIDAZOPIRIDINA
PIRAZOLOPIRIMIDINAS Y TIAZOLOPIRIMIDINAS SUSTITUIDAS
DERIVADOS DE TRIAZOL COMO INHIBIDORES DE 11-BETA-HIDROXIESTEROIDE-DESHIDROGENASA-1
MODULACION DE LA EXPRESION DEL RECEPTOR DE GLUCAGON
USO DE SDF-1 PARA EL TRATAMIENTO Y/O PREVENCIÓN DE ENFERMEDADES NEUROLÓGICAS.